1.	Phase III Chemotherapy with CDDP/5-FU with vs without Immunorestorative Therapy with DTC in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MDA-DM-8523, NCI-V85-0245
2.	Phase II Pilot Study of Toxicity Attenuation with Diethyldithiocarbamate in Patients with Epithelial Ovarian Cancer Receiving High-Dose CACP or High-Dose CBDCA Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-87-C-18B, NCI-T87-0055N, T87-0055
3.	Phase II Limited Study of Diethyldithiocarbamate to Protect Against CDDP/CTX-Induced Toxicity in Patients with Advanced Malignancies Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MSKCC-89022, NCI-V89-0109
4.	Phase II Study of Second-Line CBDCA with DTC Used as a Bone Marrow Protective Agent in Patients with Ovarian or Fallopian Tube Cancer or Adenocarcinoma of the Peritoneum who have Previously Responded to CDDP- or CBDCA-based Chemotherapy Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MSKCC-91049, NCI-V91-0119